For the year ending 2025-12-31, ABT has $86,713M in assets. $8,522M in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 8,522 | 7,616 | 6,896 | 9,882 |
| Investments, primarily bank time deposits and u.s. treasury bills | 417 | 351 | 383 | 288 |
| Trade receivables, less allowances of 2025 490 2024 439 | 7,929 | 6,925 | 6,565 | 6,218 |
| Finished products | 3,976 | 3,700 | 3,946 | 3,805 |
| Work in process | 904 | 840 | 807 | 680 |
| Materials | 1,608 | 1,654 | 1,817 | 1,688 |
| Total inventories | 6,488 | 6,194 | 6,570 | 6,173 |
| Other prepaid expenses and receivables | 2,640 | 2,570 | 2,256 | 2,663 |
| Total current assets | 25,996 | 23,656 | 22,670 | 25,224 |
| Investments | 918 | 886 | 799 | 766 |
| Land | 541 | 528 | 529 | 511 |
| Buildings | 4,543 | 4,207 | 4,161 | 4,053 |
| Equipment | 17,571 | 15,517 | 15,179 | 14,164 |
| Construction in progress | 2,567 | 2,488 | 2,064 | 1,484 |
| Property and equipment, at cost | 25,222 | 22,740 | 21,933 | 20,212 |
| Less accumulated depreciation and amortization | 13,406 | 12,082 | 11,779 | 11,050 |
| Net property and equipment | 11,816 | 10,658 | 10,154 | 9,162 |
| Intangible assets, net of amortization | 5,526 | 6,647 | 8,815 | 10,454 |
| Goodwill | 24,035 | 23,108 | 23,679 | 22,799 |
| Deferred income taxes and other assets | 18,422 | 16,459 | 7,097 | 6,033 |
| Total assets | 86,713 | 81,414 | 73,214 | 74,438 |
| Trade accounts payable | 4,240 | 4,195 | 4,295 | 4,607 |
| Salaries, wages, and commissions | 1,745 | 1,701 | 1,597 | 1,556 |
| Other accrued liabilities | 5,812 | 5,143 | 5,422 | 5,845 |
| Dividends payable | 1,097 | 1,024 | 955 | 887 |
| Income taxes payable | 569 | 594 | 492 | 343 |
| Current portion of long-term debt | 3,033 | 1,500 | 1,080 | 2,251 |
| Total current liabilities | 16,496 | 14,157 | 13,841 | 15,489 |
| Long-term debt | 9,896 | 12,625 | 13,599 | 14,522 |
| Defined benefit pension plans and post-employment medical and dental plans for significant plans | 2,125 | 1,880 | 1,964 | 1,784 |
| Net unrecognized tax benefits | 1,397 | - | - | - |
| Deferred income taxes | 559 | 512 | 568 | 991 |
| Operating lease liabilities | 931 | 896 | 949 | 943 |
| All other | 2,538 | 3,443 | 3,466 | 3,804 |
| Post-employment obligations and other long-term liabilities | 7,550 | 6,731 | 6,947 | 7,522 |
| Preferred shares, one dollar par value authorized 1,000,000 shares, none issued | 0 | 0 | 0 | 0 |
| Common shares, without par value authorized 2,400,000,000 shares issued at stated capital amount shares 2025 1,996,795,525 2024 1,991,472,630 | 25,527 | 25,153 | 24,869 | 24,709 |
| Common shares held in treasury, at cost shares 2025 260,196,074 2024 259,774,639 | 17,177 | 16,844 | 15,981 | 15,229 |
| Earnings employed in the business | 49,781 | 47,261 | 37,554 | 35,257 |
| Accumulated other comprehensive income (loss) | -6,001 | -7,906 | -7,839 | -8,051 |
| Total abbott shareholders investment | 52,130 | 47,664 | 38,603 | 36,686 |
| Noncontrolling interests in subsidiaries | 641 | 237 | 224 | 219 |
| Total shareholders investment | 52,771 | 47,901 | 38,827 | 36,905 |
| Total liabilities and shareholders' investment | 86,713 | 81,414 | 73,214 | 74,438 |
ABBOTT LABORATORIES (ABT)
ABBOTT LABORATORIES (ABT)